Merry Christmas 2021
Merry Christmas from Team NSGO-CTUđ arrow-icon-size3 Back To Overview & Happy Newyear 2021
DATA – OC in Scandinavia
Data collection is crucial in cancer studies and can help provide valuable insights into side effects, survival and prevention. In addition, health care providers can plan treatment for patients far more effectively when presenting knowledge about the number of cancer cases. Fortunately, some of the best ovarian cancer registries can be found in northern and […]
ENGOT – RUSSCO STATEMENT
ENGOT Statement With the ongoing war in Ukraine, ENGOT hereby suspends the membership of all Russian and Belorussian study groups (e.g. RUSSCO), organizations and trial sites. In addition, the ENGOT will not support any trials involving Russian or Belorussian sites . We, therefore, urge all pharmaceutical companies not to open any new sites and to […]
ENGOT CPH 2021
ENGOT 2021 Bernstorff Castle – Copenhagen The 30th of September and 1st of October, the ENGOT General Assembly 2021 was held at Bernstorff Slot in Copenhagen, Denmark. The NSGO-CTU Medical Director, Mansoor Raza Mirza, our two Deputy Medical Directors, Kristine Madsen & Kristina Lindemann, our Clinical Trial Leader, Nicole Buchner Vinum and four of our […]
New PM’s
Welcome to two new Project Managers We would like to welcome our two new Project Managers of NSGO-CTU Office, Birthe Hygum Kryhlmand and Johanne Hestvang. We look forward to the collaboration! arrow-icon-size3 Back To Overview
ESGO 2021
Our Medical Director and Vice-chairman of ESGO at the annual meeting In Prauge. We are looking very much forward to the NSGO-CTU Investigator meeting in Copenhagen this week arrow-icon-size3 Back To Overview Mansoor Raza Mirza
ESMO KEYNOTE-826
ESMO – European Society for Medical Oncology 2021 Adding pembrolizumab to standard platinum-based chemotherapyâwith or without bevacizumabâsignificantly improved progression-free survival in women with metastatic cervical cancer, KEYNOTE-826 investigators reported. âOur data suggest that this may be a new standard-of-care,â Nicoletta Colombo, MD, of the Department of Medicine and Surgery University of MilanâBicocca, and Division of […]
Swiss-GO
Swiss-GO NSGO-CTU had the honor and pleasure of hosting our ENGOT collaborators, SwissGo from Basel today to give a presentation of our offices and work. SwissGo from Basel today to give a presentation of our offices and work. arrow-icon-size3 Back To Overview
Deputies of NSGO-CTU
NSGO-CTU’s Deputy Medical Directors Welcome to the NSGO-CTU LinkedIn profile. We would like to use this first post to welcome our two new Deputy Medical Directors, Kristine Madsen and Kristina Lindemann. We are looking forward to the collaboration. We would also like to thank the former deputy Medical director Johanna Mäenpää for the collaboration through […]
Solero
ENGOT/OV64/NSGO-CTU-SOLERO It is a great pleasure to announce, that we have executed the contract on NSGO-CTU sponsored phase II randomized trial with Apexigen. The name of the trial will be ENGOT.OV64/NSGO-CTU-SOLERO. This is great news since it is the first trial globally in ovarian cancer evaluating a CD40 agonist with or without radiation therapy in […]
